165 related articles for article (PubMed ID: 15880042)
1. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.
Maki T; Gottschalk R; Ogawa N; Monaco AP
Transplantation; 2005 May; 79(9):1051-5. PubMed ID: 15880042
[TBL] [Abstract][Full Text] [Related]
2. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
Maki T; Gottschalk R; Monaco AP
Transplantation; 2002 Dec; 74(12):1684-6. PubMed ID: 12499880
[TBL] [Abstract][Full Text] [Related]
3. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.
Morris MA; McDuffie M; Nadler JL; Ley K
Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767
[TBL] [Abstract][Full Text] [Related]
4. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Penaranda C; Tang Q; Ruddle NH; Bluestone JA
Diabetes; 2010 Jun; 59(6):1461-8. PubMed ID: 20299465
[TBL] [Abstract][Full Text] [Related]
5. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Brinkmann V; Nadler JL; Lynch KR
Clin Immunol; 2003 Apr; 107(1):30-5. PubMed ID: 12738247
[TBL] [Abstract][Full Text] [Related]
6. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
7. Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.
Chen X; Ye S; Zhang S; Li J; Zhu H; Zheng G; Lu Y; Wan H
Int J Mol Sci; 2012; 13(5):6129-37. PubMed ID: 22754354
[TBL] [Abstract][Full Text] [Related]
8. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
Ogawa N; Minamimura K; Kodaka T; Maki T
J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
[TBL] [Abstract][Full Text] [Related]
9. The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat.
Popovic J; Kover KL; Moore WV
Pediatr Diabetes; 2004 Mar; 5(1):3-9. PubMed ID: 15043683
[TBL] [Abstract][Full Text] [Related]
10. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
[TBL] [Abstract][Full Text] [Related]
11. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
12. Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720.
Suzuki K; Yan H; Li XK; Amemiya H; Suzuki S; Hiromitsu K
Transplant Proc; 1998 Jun; 30(4):1044-5. PubMed ID: 9636421
[No Abstract] [Full Text] [Related]
13. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
14. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.
Jörns A; Rath KJ; Terbish T; Arndt T; Meyer Zu Vilsendorf A; Wedekind D; Hedrich HJ; Lenzen S
Endocrinology; 2010 Aug; 151(8):3555-65. PubMed ID: 20501676
[TBL] [Abstract][Full Text] [Related]
15. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
16. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
17. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
[TBL] [Abstract][Full Text] [Related]
18. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
19. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Moon H; Chon J; Joo J; Kim D; In J; Lee H; Park J; Choi J
Diabetes Metab Res Rev; 2013 Jan; 29(1):19-24. PubMed ID: 22936676
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
